Search Results - "SORENSEN, Sonja V"

Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting by Zheng, Ying, MS, MHSA, Sorensen, Sonja V., MPH, Gonschior, Ann-Katrin, PhD, Noack, Herbert, PhD, Heinrich-Nols, Jutta, MD, Sunderland, Tom, MSc, Kansal, Anuraag R., PhD

“…Abstract Purpose Three new oral anticoagulants (NOACs) have recently become available in the United Kingdom as an alternative to warfarin in the prevention of…”
Get full text

Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation by Sorensen, Sonja V., MPH, Dewilde, Sarah, MSc, Singer, Daniel E., MD, Goldhaber, Samuel Z., MD, Monz, Brigitta U., MD, Plumb, Jonathan M., MSc

“…Background and Purpose Previous cost-effectiveness analyses analyzed warfarin for stroke prevention in randomized trial settings. Given the complexities of…”
Get full text

Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation by Kansal, Anuraag R., PhD, Zheng, Ying, MS, MHSA, Pokora, Tiffany, PharmD, Sorensen, Sonja V., MPH

“…Atrial fibrillation (AF) is a common arrhythmia and the leading cause of stroke, an event with high human and economic burden. Novel oral anticoagulants have…”
Get full text

A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients by McCollum, Marianne, PhD, RPh, Sorensen, Sonja V., MPH, Liu, Larry Z., MD, PhD

“…Abstract Objectives: This study compared the costs and hospital length of stay (LOS) and duration of intravenous therapy associated with intravenous/oral…”
Get full text

Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia by Sorensen, Sonja V., MPH, Frick, Kevin D., PhD, Wade, Alexander, BA, Simko, Robert, PharmD, Burge, Russel, PhD

“…Abstract Background: The National Cholesterol Education Program Adult Treatment Panel III guidelines recommend maintaining lipid levels within particular…”
Get full text

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation by Kansal, Anuraag R, Sorensen, Sonja V, Gani, Ray, Robinson, Paul, Pan, Feng, Plumb, Jonathan M, Cowie, Martin R

“…To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant, versus warfarin and other alternatives for the prevention of stroke and…”
Get more information

Modeling Clinical Outcomes in Prostate Cancer: Application and Validation of the Discrete Event Simulation Approach by Pan, Feng, Reifsnider, Odette, Zheng, Ying, Proskorovsky, Irina, Li, Tracy, He, Jianming, Sorensen, Sonja V.

“…Treatment landscape in prostate cancer has changed dramatically with the emergence of new medicines in the past few years. The traditional survival partition…”
Get full text

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective by Sorensen, S V, Kansal, A R, Connolly, S, Peng, S, Linnehan, J, Bradley-Kennedy, C, Plumb, J M

“…Oral dabigatran etexilate is indicated for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is…”
Get more information

Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness by Kansal, Anuraag R, Sharma, Michael, Bradley-Kennedy, Carole, Clemens, Andreas, Monz, Brigitta U, Peng, Siyang, Roskell, Neil, Sorensen, Sonja V

“…Canadian patients with atrial fibrillation (AF) in whom anticoagulation is appropriate have two new choices for anticoagulation for prevention of stroke and…”
Get more information

How Inducing Covariation in Simulated HDL-C, Triglyceride, and Total Cholesterol Data Affects Framingham Risk Equation Results by Frick, Kevin D., PhD, Sorensen, Sonja V., MPH, Hollenbeak, Christopher, PhD

“…Abstract Objective To assess the effect of inducing covariation among simulated high-density lipoprotein (HDL-C), triglyceride, and total cholesterol values on…”
Get full text

Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration‐naive prostate cancer: Results from LATITUDE by Li, Tracy, Franco‐Villalobos, Conrado, Proskorovsky, Irina, Sorensen, Sonja V., Tran, NamPhuong, Sulur, Giri, Chi, Kim N.

“…Background Abiraterone acetate plus prednisone (AA+P), when added to androgen deprivation therapy (ADT), demonstrated significant improvements in overall…”
Get full text

COMPARISON OF HEALTH AND ECONOMIC OUTCOMES OF NEW ORAL ANTICOAGULANTS FOR THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION by Zheng, Ying, Sorensen, Sonja V, Menown, Ian, Gonschior, Ann-Katrin, Kleine, Eva, Heinrich-Nols, Jutta, Ghouse, Ray, Kansal, Anuraag R

“…Results Over the lifetime horizon, the model found dabigatran patients had the lowest risk of ischemic stroke and intracranial haemorrhage, followed by…”
Get full text

Incidence-based cost-of-illness model for metastatic breast cancer in the United States by Sorensen, Sonja V, Goh, Jo Wern, Pan, Feng, Chen, Connie, Yardley, Denise, Martín, Miguel, Knopf, Kevin, Benedict, Agnes, Giorgetti, Carla, Iyer, Shrividya

“…This study aims to estimate the annual U.S. societal costs associated with treatment of metastatic breast cancer (MBC) patients using an incidence-based…”
Get more information

A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation by Sorensen, Sonja V., Peng, Siyang, Monz, Brigitta U., Bradley-Kennedy, Carole, Kansal, Anuraag R.

“…Background A number of models exploring the cost-effectiveness of dabigatran versus warfarin for stroke prevention in atrial fibrillation have been published…”
Get full text

Atopic dermatitis is associated with a decrement in health-related quality of life by Kiebert, Gwendoline, Sorensen, Sonja V., Revicki, Dennis, Fagan, Susan C., Doyle, Joseph J., Cohen, Joel, Fivenson, David

“…Background Although atopic dermatitis is a chronic skin disease that can have a major impact on a patient’s life, the burden of illness associated with this…”
Get full text

Modeling hard clinical end-point data in economic analyses by Kansal, Anuraag R, Zheng, Ying, Palencia, Roberto, Ruffolo, Antonio, Hass, Bastian, Sorensen, Sonja V

“…The availability of hard clinical end-point data, such as that on cardiovascular (CV) events among patients with type 2 diabetes mellitus, is increasing, and…”
Get more information

Impact of Linezolid on Economic Outcomes and Determinants of Cost in a Clinical Trial Evaluating Patients with MRSA Complicated Skin and Soft-Tissue Infections by McKinnon, Peggy S, Sorensen, Sonja V, Liu, Larry Z, Itani, Kamal MF

“…In clinical trials, linezolid has demonstrated higher clinical cure rates and shorter hospital duration for patients than has vancomycin for the treatment of…”
Get full text

Cost-Effectiveness of Linezolid versus Vancomycin for Hospitalised Patients with Complicated Skin and Soft-Tissue Infections in Germany by Schürmann, Dirk, Sorensen, Sonja V., De Cock, Erwin, Duttagupta, Sandeep, Resch, Ansgar

“…This study used a decision analytic model approach to evaluate the cost-effectiveness of linezolid versus vancomycin in the empirical treatment of complicated…”
Get full text

A taxonomy and economic consequences of nursing home falls by SORENSEN, Sonja V, DE LISSOVOY, Gregory, KUNAPRAYOON, Dan, RESNICK, Barbara, RUPNOW, Marcia F. T, STUDENSKI, Stephanie

“…Falls are a primary cause of injury and disability in the nursing home environment and can be costly to treat. We propose a taxonomy of nursing home falls that…”
Get full text

The economics of selective serotonin reuptake inhibitors in depression: A critical review by FRANK, Lori, REVICKI, Dennis A, SORENSEN, Sonja V, SHIH, Ya-Chen Tina

“…The prevalence of depression and the high costs associated with its treatment have increased interest in pharmacoeconomic evaluations of drug treatment,…”
Get full text